India's ban on e-cigarettes and heated tobacco under scrutiny

Dec.08.2022
India's ban on e-cigarettes and heated tobacco under scrutiny
India bans e-cigarettes and heated tobacco products, but experts argue the policy is ineffective and harms consumers.

On December 2, 2019, the upper house of India's parliament approved a ban on e-cigarettes and heated tobacco products citing the World Health Organization's guidelines about the threat posed to young people.


Three years later, consumer advocates and experts in reducing tobacco harm state that the ban has been ineffective, as no safety checks or measures to combat the black market have been implemented, resulting in even greater harm.


According to public health expert and former director of the UK anti-smoking organization Action on Smoking and Health (ASH), Clive Bates, "From a large body of research, we know that electronic cigarettes are far less harmful than smoking and are replacing combustible tobacco. Therefore, allowing the sale of deadly cigarettes while banning electronic cigarettes is a ridiculous policy.


Bates presented information during a webinar organized by the Association of Vapers India (AVI), a non-profit consumer organization representing the interests of 270 million tobacco users in the country.


Jagannath Sarangapani, a member of the AVI that organized the event, said, "This ban has had a negative impact on over 100 million smokers in India, depriving them of their basic rights to health, choice, and a good life.


A web seminar titled "The Necessity of Developing Countries to Reduce Tobacco Harm" was held, with speakers and panel members from around the world, including Asia, Africa, and Latin America where 80% of tobacco users reside.


Every smoker is different and they need all available options to quit smoking. Taking away any one option would harm people and result in deaths," said Charles Gardner, Executive Director of INNCO, an organization made up of consumer groups from 37 countries, and former health commissioner at the U.S. embassy in India.


Peter Dator, of the Philippine consumer organization, stated that this decision could potentially reduce the country's smoking rate and could serve as a model for other developing countries. The regulation provides controlled access for adult smokers while also protecting minors. The law distinguishes between smoking and safer nicotine products.


Dr. Jasjit Ahluwalia, a public health scientist at Brown University in the United States, expressed regret about India's lack of safer nicotine alternatives. "Reducing harm is a well-established concept, but we have not accepted alternative products in tobacco control because we dislike the industry so much that we have forgotten about smokers," he said. Learning that India has banned nicotine alternatives and even research on alternative products, he feels upset. "This is tragic. Science should provide information for policy.


The main author of the "Global State of Tobacco Harm Reduction" report, Harry Shapiro, has raised doubts about the Indian government's justification for the "Protecting Youth" ban. According to Shapiro, "India's latest global youth tobacco survey data reveals that 7 million schoolchildren used cigarettes in the past 30 days, and 3,000 used e-cigarettes. Therefore, this ban is more about money and politics than public health.


Many speakers also emphasized the role played by organizations sponsored by the WHO and Bloomberg in promoting the ban of new nicotine products in developing countries. Joseph Magero, a former tobacco control advocate in Kenya, stated that the WHO's ideological approach had been unsuccessful.


History has shown us time and time again that prohibition does not work. Prohibiting alcohol has led to an illegal market. Banning these products not only fails to achieve public health goals, but instead pushes them into unregulated and uncontrollable black markets," he remarked.


Physicist and director of a consumer non-profit organization, Roberto Sussman, has expressed support for e-cigarette users in India, stating that their situation is similar to ours due to government agencies spreading misinformation about e-cigarettes. However, we must continue to push back, despite bans on sales, as there is a black market for these products and people know that e-cigarettes can be a safer alternative.


Nancy Loucas, Executive Director of CAPHRA (Coalition of Asia-Pacific Tobacco Harm Reduction Advocates), shared some positive views and said, "There is reason to be optimistic. The harm reduction movement has begun in the East and is moving westward.


Starting from New Zealand, the trend of lifting bans on e-cigarettes is spreading to the Philippines, Indonesia and Malaysia. These countries are now also studying regulatory frameworks, while Thailand is also discussing reversing its ban on e-cigarettes. However, India needs to become the litmus test for a more comprehensive global transformation. With time, we will arrive there.


2FIRSTS will continue to provide ongoing coverage of this topic, with additional updates available on the '2FIRSTSAPP'. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04